Ledger.Open graph →
SEC Form D · Amendment · filed August 3, 2023

CeleCor Therapeutics, Inc

Offering
$42.5M
Sold
$17.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Andreas B. Ritzi · Zug, V8DirectorRobert Hillman · Del Mar, CAExec · DirectorJack B. Lief · Del Mar, CADirectorPeter B. Finn · Boston, MAExecRobert A. O'Sullivan · West Palm Beach, FLExec · DirectorSteven W. Davis · Birmingham, ALExecBenjamin Fogle · West Des Moines, IADirectorMichael S. Falk · West Palm Beach, FLDirectorMatthew Kennedy · New York, NYExecPaul J. Newfield · Wellington, Q2DirectorAlexandre M. Kaoukhov · Singapore, U0Exec · DirectorNeil Graham, Mbbs, M.D., Mph · Singapore, U0Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗